GSK supplemental application for Jemperli plus chemotherapy accepted by USFDA for endometrial cancer Ruchika Sharma6 Jun 2023 3:28 PM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
GSK Pharma reports net profit at Rs 133 crore in Q4 Ruchika Sharma18 May 2023 2:30 PM ISTFor FY23, consolidated net profit from continuing operations was Rs 607.64 crore against Rs 380.77 crore in FY22.
US Supreme Court rejects Teva challenge to USD 235 million GSK award in patent dispute Ruchika Sharma16 May 2023 2:44 PM ISTGSK responded in a court brief that the case "presents no threat to generic companies who operate properly under the law."
Canada court dismissed Zantac litigation: GSK Ruchika Sharma13 May 2023 12:30 PM ISTBengaluru: The British Columbia Supreme Court dismissed a proposed class action in Canada against heartburn drug Zantac over increased cancer risk,...
GSK raises USD 1 billion selling shares in Haleon Consumer Spinoff: Bloomberg Ruchika Sharma12 May 2023 12:30 PM ISTSince the spinoff, GSK has said that it intended to treat its stake in Haleon like a financial investment.
Pfizer plan to sell its Haleon stake is not surprise: Consumer health company Finance chief Ruchika Sharma4 May 2023 1:30 PM ISTHestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained...
World's first RSV vaccine: GSK wins USFDA nod for Arexvy in older adults Ruchika Sharma4 May 2023 11:48 AM ISTRespiratory syncytial virus is a common contagious virus affecting the lungs and breathing passages.
GSK gets positive EMA panel opinion for Respiratory syncytial virus older adult vaccine Ruchika Sharma29 April 2023 2:30 PM ISTGSK's RSV older adult vaccine candidate contains a recombinant subunit RSV prefusion F glycoprotein antigen (RSVPreF3) combined with the Company's...
GSK beats expectations for Q1 revenue, profit Ruchika Sharma27 April 2023 2:30 PM ISTLondon: GSK on Wednesday beat expectations for its first-quarter revenue and profit, helped by sales of its blockbuster shingles vaccine Shingrix.The...
GSK Shingles vaccine Shingrix now in India Ruchika Sharma26 April 2023 3:27 PM ISTShingrix is a non-live vaccine it can be offered to those, above the age of 50 years, who are immunocompromised and/or immunosuppressed and who are...
GSK plans to acquire Bellus Health for USD 2 billion Ruchika Sharma18 April 2023 5:05 PM ISTAt the heart of the deal - announced by both companies on Tuesday - is the experimental drug, camlipixant, which is in late-stage development for...
GSK oral antibiotic drug to treat uncomplicated urinary tract infections meets main goals in late stage trials Ruchika Sharma17 April 2023 2:39 PM ISTThe drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat...
